Latest Research Report of Prostate Cancer Diagnostics Market (COVID-19) to Witness Astonishing Growth by Forecast 2020-2028 | Top Key Players Like MDxHealth,3D Signatures,Genomic Health,Abbott,OPKO Health, INC.,Siemens Healthcare GmbH,DiaSorin S.p.A,BioMerieux SA,F. Hoffman La Roche Ltd.,Beckman Coulter, INC.,Myriad Genetic Inc

The global prostate cancer diagnostics market size was valued at USD 2.83 billion in 2020 and is anticipated to expand at a CAGR of 14% during the forecast period.

Prostate Cancer is an unusual and unbounded growth of cells in the prostate glands of the male. According to World Health Organization (WHO), prostate cancer is the second most common cancer in men. In 2012, an estimated 1.1 million men worldwide were diagnosed with prostate cancer, reckoning for 15% of the cancers diagnosed in men. With an estimated 307,000 deaths in 2012, prostate cancer is the fifth leading cause of death from cancer in men (6.6% of the total deaths among men).

Rise in government initiatives to develop new technologies to enhance diagnosis is expected to impact the market positively. For instance, the National Cancer Institute initiated Prostate Specialized Programs of Research Excellence (SPORE)-a program designed to convert scientific findings into clinical settings based outcomes. The institute also facilitates the development of new technologies and studies to gain a better understanding of monitoring, prevention, diagnosis, and treatment.

Free Sample Report + All Related Graphs & Charts @:

The rising number of new market entrants is another factor anticipated to fuel the growth of the prostate cancer diagnostics market in near future. For instance, in July 201, 9Gregor Diagnostics, invested USD 9,00,000 to support its efforts to develop a novel at-home screening test. This device is expected to facilitate highly sensitive test results in comparison to common PSA tests. Thus, increasing investment by new entrants is expected to drive the growth significantly. However, the high cost of the tests is anticipated to hinder growth.

Key Players:

  • Blue Earth Diagnostics Limited
  • Progenics Pharmaceuticals, Inc.
  • Telix Pharmaceuticals Ltd.
  • ABX Advanced Biochemical Compounds GmbH
  • Jubilant Radiopharma
  • Lantheus Medical Imaging, Inc.
  • Advanced Accelerator Applications (Novartis AG)
  • Theragnostics

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios. The report also gives an industry-wide competitive analysis, highlighting the different market segments, individual market share of leading players, and the contemporary market scenario and the most vital elements to study while assessing the global Prostate Cancer Nuclear Medicine Diagnostics market.

The Prostate Cancer Nuclear Medicine Diagnostics market report is extensively categorized into different product types and applications. The study has a separate section for explaining the cost of raw material and the revenue returns that are gained by the players of the market. The segmentation included in the report is beneficial for readers to capitalize on the selection of appropriate segments for the Prostate Cancer Nuclear Medicine Diagnostics sector and can help companies in deciphering the optimum business move to reach their desired business goals.

Market segmentation by type:

  • PET

Market segmentation by product type:

  • F-18
  • C11
  • GA 68 PSMA

Market segmentation by scan type:

  • Bone scan
  • Ultrasound
  • Computerized tomography (CT) scan
  • Magnetic resonance imaging (MRI)
  • Positron emission tomography (PET) scan

Market segmentation by applications:

  • Hospitals
  • Clinics
  • Others

Hurry…!!! Discount (upto 40%) available on this Report @

The research study includes the latest updates about the COVID-19 impact on the Prostate Cancer Nuclear Medicine Diagnostics sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

The Prostate Cancer Nuclear Medicine Diagnostics market report provides successfully marked contemplated policy changes, favorable circumstances, industry news, developments, and trends. This information can help readers fortify their market position. It packs various parts of information gathered from secondary sources, including press releases, web, magazines, and journals as numbers, tables, pie-charts, and graphs. The information is verified and validated through primary interviews and questionnaires. The data on growth and trends focuses on new technologies, market capacities, raw materials, CAPEX cycle, and the dynamic structure of the Prostate Cancer Nuclear Medicine Diagnostics market.

This study analyzes the growth of Prostate Cancer Nuclear Medicine Diagnostics based on the present, past and futuristic data and will render complete information about the Prostate Cancer Nuclear Medicine Diagnostics industry to the market-leading industry players that will guide the direction of the Prostate Cancer Nuclear Medicine Diagnostics market through the forecast period. All of these players are analyzed in detail so as to get details concerning their recent announcements and partnerships, product/services, and investment strategies, among others.

Enquire for customization in Report @

The report contains historical revenue and volume that backing information about the market capacity, and it helps to evaluate conjecture numbers for key areas in the Prostate Cancer Nuclear Medicine Diagnostics market. Additionally, it includes a share of each segment of the Prostate Cancer Nuclear Medicine Diagnostics market, giving methodical information about types and applications of the market.

In the end, the Prostate Cancer Nuclear Medicine Diagnostics market is analyzed for revenue, sales, price, and gross margin. These points are examined for companies, types, applications, and regions. To summarize, the global Prostate Cancer Nuclear Medicine Diagnostics market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:
Market Research Inc is farsighted in its view and covers the massive ground in global research. Local or global, we keep a close check on both markets. Trends and concurrent assessments sometimes overlap and influence the other. When we say market intelligence, we mean a deep and well-informed insight into your products, market, marketing, competitors, and customers. Market research companies are leading the way in nurturing global thought leadership. We help your product/service become the best they can with our informed approach.

Contact Us:
Author Kevin
US Address: 51 Yerba Buena Lane, Ground Suite,
Inner Sunset San Francisco, CA 94103, USA
Call Us: +1 (628) 225 1818



Back to top button